HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center.

AbstractOBJECTIVE:
The current study aimed at comparison of retention rates for daily dispensing (DD) and alternate-day dispensing (AD) regimens for buprenorphine over a 1-year period at a tertiary care treatment center for management of substance use disorders. Additionally, it aimed at comparison of prescription refill proportions for these two buprenorphine dispensing regimens over a 1-year period.
SETTING:
The study was conducted at a tertiary level substance use disorder treatment center.
PATIENTS, PARTICIPANTS:
Case records of patients satisfying the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria for opioid dependence syndrome were included in the study.
MAIN OUTCOME MEASURES:
Retention rates and prescription refill proportions were compared for the two buprenorphine dispensing regimens for different time intervals over a 52-week period.
RESULTS:
Fifty-two subjects (45.61 percent) were started on DD regimen and 62 (54.38 percent) were put on AD regimen of buprenorphine. All subjects were opioid dependent. The two groups did not differ for prescription refill proportions as well as retention rates for any of the time intervals studied.
CONCLUSION:
The findings of the current study support feasibility and acceptance of alternate-day dosing strategy for buprenorphine dispensing for patients with opioid dependence.
AuthorsYatan Pal Singh Balhara
JournalJournal of opioid management (J Opioid Manag) 2014 May-Jun Vol. 10 Issue 3 Pg. 200-6 ISSN: 1551-7489 [Print] United States
PMID24944070 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Narcotic Antagonists
  • Buprenorphine
Topics
  • Adult
  • Buprenorphine (administration & dosage)
  • Drug Administration Schedule
  • Humans
  • Middle Aged
  • Narcotic Antagonists (administration & dosage)
  • Opioid-Related Disorders (drug therapy)
  • Tertiary Healthcare

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: